Tag | Content |
---|---|
UniProt Accession | ROA2_HUMAN; P22626; |
Entrez ID | 3181 |
GenBank Protein ID | NM_002137.3; NM_031243.2; XM_005249729.1; XM_017012109.1; XM_017012110.1; |
GenBank Nucleotide ID | NP_002128.1; NP_112533.1; XP_005249786.1; XP_016867598.1; XP_016867599.1; |
Protein Name | Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1) |
Gene Name | HNRNPA2B1; HNRPA2B1 |
Organism | Homo sapiens |
NCBI Taxa ID | 9606 |
Functional Description | Heterogeneous nuclear ribonucleoprotein (hnRNP) that associates with nascent pre-mRNAs, packaging them into hnRNP particles. The hnRNP particle arrangement on nascent hnRNA is non-random and sequence-dependent and serves to condense and stabilize the transcripts and minimize tangling and knotting. Packaging plays a role in various processes such as transcription, pre-mRNA processing, RNA nuclear export, subcellular location, mRNA translation and stability of mature mRNAs (PubMed:19099192). Forms hnRNP particles with at least 20 other different (view all) |
Sequence (Fasta) | MEKTLETVPL ERKKREKEQF RKLFIGGLSF ETTEESLRNY YEQWGKLTDC VVMRDPASKR 60 SRGFGFVTFS SMAEVDAAMA ARPHSIDGRV VEPKRAVARE ESGKPGAHVT VKKLFVGGIK 120 EDTEEHHLRD YFEEYGKIDT IEIITDRQSG KKRGFGFVTF DDHDPVDKIV LQKYHTINGH 180 NAEVRKALSR QEMQEVQSSR SGRGGNFGFG DSRGGGGNFG PGPGSNFRGG SDGYGSGRGF 240 GDGYNGYGGG PGGGNFGGSP GYGGGRGGYG GGGPGYGNQG GGYGGGYDNY GGGNYGSGNY 300 NDFGNYNQQP SNYGPMKSGN FGGSRNMGGP YGGGNYGPGG SGGSGGYGGR SRY 354 |
|
Database | Annotation |
---|---|
Cancer Gene Census | prostate |
CTD (Curated) (count: 2) | MESH:C563476
; Inclusion Body Myopathy With Early-Onset Paget Disease And Frontotemporal Dementia MESH:D015459 ; Leukemia-Lymphoma, Adult T-Cell |
DisGeNet (Curated) (count: 18) (view all) | C0023493; Adult T-Cell Lymphoma/Leukemia
C0026848; Myopathy C0026850; Muscular Dystrophy C0027121; Myositis C0151576; Elevated creatine kinase C0233514; Abnormal behavior |
PTM | Modification Sites |
---|---|
Phosphorylation (count: 49) (view all) | 102 RAVAREESGKPGAHV dbPAF
131 EEHHLRDYFEEYGKI dbPAF 135 LRDYFEEYGKIDTIE dbPAF 140 EEYGKIDTIEIITDR dbPAF 145 IDTIEIITDRQSGKK dbPAF 149 EIITDRQSGKKRGFG dbPAF |
Acetylation (count: 11) (view all) | 104 VAREESGKPGAHVTV PLMD
112 PGAHVTVKKLFVGGI PLMD 113 GAHVTVKKLFVGGIK PLMD 120 KLFVGGIKEDTEEHH PLMD 168 DDHDPVDKIVLQKYH PLMD 17 LERKKREKEQFRKLF PLMD |
Ubiquitination (count: 12) (view all) | 104 VAREESGKPGAHVTV PLMD
112 PGAHVTVKKLFVGGI PLMD 113 GAHVTVKKLFVGGIK PLMD 120 KLFVGGIKEDTEEHH PLMD 137 DYFEEYGKIDTIEII PLMD 168 DDHDPVDKIVLQKYH PLMD |
Sumoylation (count: 9) (view all) | 104 VAREESGKPGAHVTV PLMD
120 KLFVGGIKEDTEEHH PLMD 13 ETVPLERKKREKEQF PLMD 151 ITDRQSGKKRGFGFV PLMD 152 TDRQSGKKRGFGFVT PLMD 168 DDHDPVDKIVLQKYH PLMD |
Malonylation (count: 2) | 113 GAHVTVKKLFVGGIK PLMD
120 KLFVGGIKEDTEEHH PLMD |
Methylation (count: 1) | 104 VAREESGKPGAHVTV PLMD |
Succinylation (count: 1) | 120 KLFVGGIKEDTEEHH PLMD |
Network | Interaction | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | B | Source | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|